TrialCancer immunology research2015

Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.

Rodney J Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.